Intrexon reported $201.47M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agenus AGEN:US $ 14.18M 0.63M
Amgen AMGN:US $ 36854M 3545M
Anika Therapeutics ANIK:US $ 0.12M 0.07M
Arrowhead Research ARWR:US $ 0M 0M
AstraZeneca AZN:LN 31099M 318M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44972M 419M
Chemocentryx CCXI:US $ 23.68M 0.05M
Gilead Sciences GILD:US $ 26208M 487M
GlaxoSmithKline GSK:LN 33328M 9155M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Immunogen IMGN:US $ 0M 0M
Intrexon XON:US $ 201.47M 18.32M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Ligand Pharmaceuticals LGND:US $ 176.59M 144.17M
Macrogenics MGNX:US $ 0M 0M
Mannkind MNKD:US $ 384.54M 2.84M
Merk MRK:US $ 31794M 1308M
Novartis NOVN:VX SF 31275M 250M
Peregrine Pharmaceuticals PPHM:US $ 142.03M 0.21M
Rigel Pharmaceuticals RIGL:US $ 29.85M 9.93M
Sangamo Biosciences SGMO:US $ 0M 0M
Thermo Fisher Scientific TMO:US $ 33255M 1615M
Veracyte VCYT:US $ 1.68M 0.05M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 34.18M 0.09M
Ziopharm Oncology ZIOP:US $ 24.32M 0.2M